lobbying_activities: 621765

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
621765	af5a4542-5cf2-4287-b4a4-e8091475db8c	Q2	DUTKO WORLDWIDE, LLC	12868	BIOGENIDEC	2008	second_quarter	MMM	Monitoring implementation and legislation affecting the Medicare program, the Prescription Drug User Fee Act, legislation to create a regulatory pathway for biosimiliars (Pathway for Biosimilars Act (H.R. 5629)) and other major health care initiatives before Congress.	Commerce, Dept of (DOC),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2008-07-02T13:41:19-04:00